The primary objective is to assess safety and efficacy of AU-011 via suprachoroidal injection to treat primary indeterminate lesions and small choroidal melanoma.
Supplementary data B Any reported adverse event that occurred in less than 5% of any group – grouped under the primary System Organ Class, according to the MedDRA coding system.
AimThis study comprehensively analyzed the characteristics and development trends of pediatric interventional drug clinical trials registered between 2015 and 2024, with a focus on pharmaceutical char